Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy
- PMID: 8857718
- DOI: 10.1212/wnl.47.4.912
Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy
Abstract
Objective: To determine the proportion and characteristics of children presenting with childhood absence epilepsy (CAE) who were not taking anti-epileptic drugs (AEDs) and were seizure-free over the last year of long-term follow-up.
Methods: For case finding, centralized EEG records for the province of Nova Scotia allowed identification of all children with typical CAE diagnosed between 1977 and 1985. Follow-up was done in 1994 to 1995.
Results: Of 81 children with CAE, 72 (89%) were contacted for follow-up. Mean age at seizure onset was 5.7 years (range, 1 to 14 years) and at follow-up was 20.4 years (range, 12 to 31 years). Forty-seven (65%) were in remission. Twelve others (17%) were not taking AEDs but continued to have seizures. Thirteen (18%) were taking AEDs; five were seizure-free over the last year (in four of these a trial without AEDs had previously failed). Fifteen percent of the total cohort had progressed to juvenile myoclonic epilepsy (JME). Multiple clinical and EEG factors were examined as predictors of outcome. Factors predicting no remission (p < 0.05) included cognitive difficulties at diagnosis, absence status prior to or during AED treatment, development of generalized tonic clonic or myoclonic seizures after onset of AEDs, abnormal background on initial EEG, and family history of generalized seizures in first-degree relatives.
Conclusions: Only 65% of children presenting with CAE had remission of their epilepsy. Forty-four percent of those without remission had developed JME. At the time of diagnosis, remission is difficult to predict accurately in most patients. However, development of generalized tonic-clonic seizures or myoclonic seizures during AED treatment is ominous, predicting both lack of remission of CAE and progression to JME.
Comment in
-
Long-term prognosis of typical childhood absence epilepsy.Neurology. 1997 Oct;49(4):1187. doi: 10.1212/wnl.49.4.1187. Neurology. 1997. PMID: 9339731 No abstract available.
Similar articles
-
Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy.Epilepsia. 2001 Jun;42(6):760-3. doi: 10.1046/j.1528-1157.2001.02401.x. Epilepsia. 2001. PMID: 11422332
-
Long-term prognosis for childhood and juvenile absence epilepsy.J Neurol. 2004 Oct;251(10):1235-41. doi: 10.1007/s00415-004-0521-1. J Neurol. 2004. PMID: 15503104
-
Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up.Brain. 2006 May;129(Pt 5):1269-80. doi: 10.1093/brain/awl048. Epub 2006 Mar 6. Brain. 2006. PMID: 16520331
-
Management guidelines for children with idiopathic generalized epilepsy.Epilepsia. 2005;46 Suppl 9:112-6. doi: 10.1111/j.1528-1167.2005.00322.x. Epilepsia. 2005. PMID: 16302884 Review.
-
A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME).PLoS One. 2024 Apr 9;19(4):e0300930. doi: 10.1371/journal.pone.0300930. eCollection 2024. PLoS One. 2024. PMID: 38593118 Free PMC article.
Cited by
-
Therapeutic Outcomes and Prognostic Factors in Childhood Absence Epilepsy.J Clin Neurol. 2016 Apr;12(2):160-5. doi: 10.3988/jcn.2016.12.2.160. Epub 2015 Nov 26. J Clin Neurol. 2016. PMID: 26610892 Free PMC article.
-
Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets.Neurobiol Dis. 2023 Jun 1;181:106094. doi: 10.1016/j.nbd.2023.106094. Epub 2023 Mar 27. Neurobiol Dis. 2023. PMID: 36990364 Free PMC article. Review.
-
Sleep and Epilepsy Link by Plasticity.Front Neurol. 2020 Aug 28;11:911. doi: 10.3389/fneur.2020.00911. eCollection 2020. Front Neurol. 2020. PMID: 32982931 Free PMC article.
-
Absence Epilepsy: Older vs Newer AEDs.Curr Treat Options Neurol. 2014 May;16(5):290. doi: 10.1007/s11940-014-0290-9. Curr Treat Options Neurol. 2014. PMID: 24668022
-
The developmental evolution of the seizure phenotype and cortical inhibition in mouse models of juvenile myoclonic epilepsy.Neurobiol Dis. 2015 Oct;82:164-175. doi: 10.1016/j.nbd.2015.05.016. Epub 2015 Jun 6. Neurobiol Dis. 2015. PMID: 26054439 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources